Drug repositioning as a therapeutic strategy for neurodegenerations associated with OPA1 mutations.
Hum Mol Genet
; 29(22): 3631-3645, 2021 01 21.
Article
in En
| MEDLINE
| ID: mdl-33231680
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neurodegenerative Diseases
/
Optic Atrophy, Autosomal Dominant
/
Drug Repositioning
/
GTP Phosphohydrolases
Type of study:
Prognostic_studies
/
Risk_factors_studies
Limits:
Animals
/
Humans
Language:
En
Journal:
Hum Mol Genet
Journal subject:
BIOLOGIA MOLECULAR
/
GENETICA MEDICA
Year:
2021
Document type:
Article
Affiliation country:
Italy
Country of publication:
United kingdom